Literature DB >> 2045151

Central hemodynamic observations in untreated preeclamptic patients.

W Visser1, H C Wallenburg.   

Abstract

Reported central hemodynamics obtained with a Swan-Ganz pulmonary artery thermodilution catheter in preeclamptic patients show marked disparity, which has been interpreted to indicate a variable hemodynamic expression of the disease. However, the variability also may be due, at least in part, to the pharmacological treatment that most of the women studied received during Swan-Ganz measurements. To evaluate the effects of treatment on hemodynamics, we compared the results of Swan-Ganz measurements in 87 preeclamptic women who had received no treatment at all with those obtained in 47 preeclamptic women who had received various drugs and intravenous fluids. Control values were obtained in 10 normotensive pregnant volunteers. Measurements were performed between 25 and 34 weeks of gestation. The median (range) cardiac index in the untreated patients of 3.3 (2.0-5.3) l.min-1.m-2 was significantly lower than that in the treated patients of 4.3 (2.4-7.6) l.min-1.m-2 and in the normotensive pregnant women of 4.2 (3.5-4.6) l.min-1.m-2. The systemic vascular resistance index in the untreated group of 3,003 (1,771-5,225) dyne.sec.cm-5.m2 was significantly higher than that of 2,212 (1,057-3,688) in the treated and of 1,560 (1,430-2,019) dyne.sec.cm-5.m2 in the normotensive control group. The median (range) pulmonary capillary wedge pressure in the untreated group was 7 (-1-20) mm Hg and did not differ from that of 7 (0-25) mm Hg in the treated group. Variability of all hemodynamic variables was much lower in untreated than in treated patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 2045151     DOI: 10.1161/01.hyp.17.6.1072

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  21 in total

1.  Fluid management in pre-eclampsia.

Authors:  John Anthony; Leann K Schoeman
Journal:  Obstet Med       Date:  2013-07-26

2.  Effects of pregnancy, hypertension and nitric oxide inhibition on rat uterine artery myogenic reactivity.

Authors:  Carolyn Barron; Maurizio Mandala; George Osol
Journal:  J Vasc Res       Date:  2010-04-30       Impact factor: 1.934

3.  Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy.

Authors:  M E Helewa; R F Burrows; J Smith; K Williams; P Brain; S W Rabkin
Journal:  CMAJ       Date:  1997-09-15       Impact factor: 8.262

Review 4.  Role of magnesium sulfate in seizure prevention in patients with eclampsia and pre-eclampsia.

Authors:  J Anthony; R B Johanson; L Duley
Journal:  Drug Saf       Date:  1996-09       Impact factor: 5.606

Review 5.  Antihypertensive therapy in pregnancy.

Authors:  J G Umans; M D Lindheimer
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

Review 6.  The hypertensive disorders of pregnancy.

Authors:  F Broughton Pipkin
Journal:  BMJ       Date:  1995-09-02

Review 7.  Peripartum Cardiomyopathy and Preeclampsia: Overlapping Diseases of Pregnancy.

Authors:  Pavan Parikh; Lori Blauwet
Journal:  Curr Hypertens Rep       Date:  2018-07-03       Impact factor: 5.369

Review 8.  Placental ischemia and cardiovascular dysfunction in preeclampsia and beyond: making the connections.

Authors:  Jeffrey S Gilbert; Mark J Nijland; Penny Knoblich
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-11

9.  Erythrocyte sodium/potassium ATPase activity in severe preeclampsia.

Authors:  C D Adair; G T Haupert; H P Koh; Y Wang; J-C Veille; V Buckalew
Journal:  J Perinatol       Date:  2009-01-22       Impact factor: 2.521

10.  Vagal withdrawal and sympathetic overactivity contribute to the genesis of early-onset pregnancy-induced hypertension.

Authors:  G K Pal; P Shyma; S Habeebullah; Pravati Pal; Nivedita Nanda; P Shyjus
Journal:  Int J Hypertens       Date:  2011-04-06       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.